TipRanks
Aptevo Therapeutics Inc (DE:AP82)
FRANKFURT:AP82
Germany Market
AP82
Aptevo Therapeutics
RESEARCH TOOLSreports

Aptevo Therapeutics (AP82) Income Statement

0 Followers

Aptevo Therapeutics Income Statement

Last quarter (Q2 2026), Aptevo Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Aptevo Therapeutics's net income was $-6.36M. See Aptevo Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 3.11M$ 12.29M
Gross Profit
$ -240.00K$ -352.00K$ 0.00$ 3.11M$ 12.29M
Operating Expenses
$ 26.07M$ 24.25M$ 28.88M$ 31.75M$ 33.69M
Depreciation and Amortization
$ 240.00K$ 352.00K$ 567.00K$ 901.00K$ 1.14M
EBITDA
$ -25.73M$ -23.78M$ -18.08M$ 7.92M$ -28.26M
Operating Income
$ -26.31M$ -24.60M$ -28.88M$ -28.64M$ -21.40M
Other Income/Expenses
$ 345.00K$ 472.00K$ 10.23M$ 35.66M$ -8.01M
Pretax Income
$ -25.97M$ -24.13M$ -18.65M$ 7.01M$ -29.41M
Net Income
$ -25.97M$ -24.13M$ -17.41M$ 8.03M$ -28.46M
Per Share Metrics
Basic EPS
$ -87.27$ -31.46K$ -834.04K$ 922.39K$ -3.56M
Diluted EPS
$ -87.27$ -31.46K$ -834.04K$ 921.91K$ -3.56M
Weighted Average Shares Outstanding
 3.15K 767.00 21.00--
Weighted Average Shares Outstanding (Diluted)
 3.15K 767.00 21.00--
Currency in USD

Aptevo Therapeutics Earnings and Revenue History